Autonomix Med Inc.
13F holders, Q2 2025 (June 30)20holders +7
8new positions
2sold out
$0.97avg. 13F price*
At the end of Q2 2025, 20 institutions reported holding Autonomix Med Inc. in their 13F filings, up 7 from Q1 2025. 8 opened new positions and 2 sold out. The largest holders were Mariner, LLC ($51K), Susquehanna International Group, LLP ($32K) and Ikarian Capital, LLC ($31K).
- Company
- Autonomix Med Inc.
- CUSIP
- 05330T205
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $77K |
| Exits | 2 | $24K |
All 13F filers, Q1 2025 → Q2 2025: 49,763 shares bought and 25,137 shares sold, net +24,626 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Mariner, LLC | 0.00% | No change | 100,643 | $51K |
| Susquehanna International Group, LLP | 0.00% | New | 20,467 | $32K |
| Ikarian Capital, LLC | 0.01% | No change | 20,000 | $31K |
| Virtu Financial LLC | 0.00% | New | 15,680 | $25K |
| Geode Capital Management, LLC | 0.00% | New | 10,035 | $16K |
| UBS Group AG | 0.00% | Reduce -72.0% | 4,461 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +29.3% | 2,804 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -10.9% | 1,638 | $3K |
| Morgan Stanley | 0.00% | New | 1,172 | $2K |
| Arax Advisory Partners | 0.00% | New | 1,000 | $2K |
| FMR LLC | 0.00% | New | 227 | $356 |
| Investors Research Corp | 0.00% | Add +1000.0% | 220 | $345 |
| Raymond James Financial Inc. | 0.00% | New | 162 | $254 |
| Bank of America Corp. | 0.00% | Add +11.1% | 10 | $16 |
| Harbour Investments, Inc. | 0.00% | No change | 10 | $16 |
| Global Retirement Partners, LLC | 0.00% | — | 10 | $16 |
| SWAN Capital LLC | 0.00% | No change | 10 | $16 |
| Osaic Holdings, Inc. | 0.00% | No change | 10 | $15 |
| National Bank of Canada | 0.00% | No change | 7 | $11 |
| Cwm, LLC | 0.00% | New | 184 | $0 |
"% of holder's portfolio" is AUTONOMIX MED INC's weight in each manager's 13F, not the share of Autonomix Med Inc. the manager owns.